These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21555624)

  • 1. Possible in vitro model of toxic epidermal necrolysis.
    Letko E; Bhol K; Foster CS; Ahmed AR
    Arch Ophthalmol; 2011 May; 129(5):666-7. PubMed ID: 21555624
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
    Gaultier F; Ejeil AL; Igondjo-Tchen S; Dohan D; Dridi SM; Maman L; Wierzba CB; Stania D; Pellat B; Lafont A; Godeau G; Gogly B
    Arch Dermatol Res; 2004 Oct; 296(5):220-5. PubMed ID: 15449075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin signs of severe systemic medication reactions.
    Treat JR
    Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):193-7. PubMed ID: 22884025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study.
    Ueta M; Sotozono C; Nakano M; Taniguchi T; Yagi T; Tokuda Y; Fuwa M; Inatomi T; Yokoi N; Tashiro K; Kinoshita S
    J Allergy Clin Immunol; 2010 Dec; 126(6):1218-25.e10. PubMed ID: 20947153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Nakajima S; Watanabe H; Tohyama M; Sugita K; Iijima M; Hashimoto K; Tokura Y; Nishimura Y; Doi H; Tanioka M; Miyachi Y; Kabashima K
    Arch Dermatol; 2011 Sep; 147(9):1110-2. PubMed ID: 21931056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Eginli A; Shah K; Watkins C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
    [No Abstract]   [Full Text] [Related]  

  • 12. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Baader's dermatostomatitis, a rare variety of erythema multiforme exudativum].
    Zorin PM; Zorin SP; Sukhova MI
    Vestn Dermatol Venerol; 1981 Aug; (8):70-3. PubMed ID: 7281988
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.
    Levitt L; Pearson RW
    JAMA; 1980 Mar; 243(12):1262-3. PubMed ID: 7359684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case of Stevens-Johnson syndrome].
    Belov AS; Vitenchuk SZ
    Vestn Dermatol Venerol; 1980 Jun; (6):59-60. PubMed ID: 7395368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.